Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants

NCT00516360 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

NIH

Sponsor class

Conditions

Catheterization

Interventions

DEVICE: 3.15% chlorhexidine as daily antiseptic on needleless access port

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]